NOVAVAX INC — Director's Dealing 2016

Feb 1, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2016-01-31

Reporting Person: Herrmann John A III (SVP, General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-01-31	Common Stock	P	2072	$4.38	Acquired	2112	Direct

Footnotes

F1: Includes 2,072 shares acquired under the Issuer's 2013 Employee Stock Purchase Plan on January 31, 2016.